The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-Bromo-N-(3-(5-(2,6-difluoro-3-hydroxybenzoyl)thiophene-2-yl)-phenyl)-2-trifluoromethoxybenzenesulfonamide ID: ALA3629585
PubChem CID: 122194410
Max Phase: Preclinical
Molecular Formula: C24H13BrF5NO5S2
Molecular Weight: 634.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(c1ccc(-c2cccc(NS(=O)(=O)c3ccc(Br)cc3OC(F)(F)F)c2)s1)c1c(F)ccc(O)c1F
Standard InChI: InChI=1S/C24H13BrF5NO5S2/c25-13-4-9-20(17(11-13)36-24(28,29)30)38(34,35)31-14-3-1-2-12(10-14)18-7-8-19(37-18)23(33)21-15(26)5-6-16(32)22(21)27/h1-11,31-32H
Standard InChI Key: FUEBVUVFPJRPIE-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 41 0 0 0 0 0 0 0 0999 V2000
4.6017 -12.1261 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4020 -12.0971 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.0271 -11.0728 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6837 -10.7794 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3383 1.3500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0031 -3.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3039 -3.7494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4469 -5.2297 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.9152 -5.5365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6607 -4.2349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6532 -3.1236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0351 -3.6026 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5304 -6.9054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7488 -8.1798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4649 -9.4979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9644 -9.5368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7478 -8.2576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0317 -6.9396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3383 -1.3500 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.3383 -1.3500 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.6208 -13.3786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3396 -14.6952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5588 -15.9759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0592 -15.9401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3405 -14.6236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1212 -13.3428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4346 -16.9647 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
0.3993 -12.0270 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.1011 -11.9933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6783 -10.9412 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-1.7239 -13.0190 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-2.3008 -11.9669 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
6 11 1 0
10 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 13 2 0
12 18 2 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
15 19 1 0
21 4 1 0
9 25 1 0
5 26 1 0
4 2 1 0
2 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 27 1 0
30 33 1 0
32 34 1 0
34 35 1 0
35 36 1 0
35 37 1 0
35 38 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 634.40Molecular Weight (Monoisotopic): 632.9339AlogP: 7.09#Rotatable Bonds: 7Polar Surface Area: 92.70Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 6.81CX Basic pKa: ┄CX LogP: 7.66CX LogD: 6.99Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.17Np Likeness Score: -1.32
References 1. Abdelsamie AS, Bey E, Gargano EM, van Koppen CJ, Empting M, Frotscher M.. (2015) Towards the evaluation in an animal disease model: Fluorinated 17β-HSD1 inhibitors showing strong activity towards both the human and the rat enzyme., 103 [PMID:26322835 ] [10.1016/j.ejmech.2015.08.030 ]